KORU Medical Systems (KRMD) EBITDA Margin (2010 - 2026)
KORU Medical Systems' (KRMD) quarterly EBITDA Margin came in at 5.21% in Q2 2026, up 827.0% year-over-year from 0.56% in Q2 2025, and up 170.8% quarter-over-quarter from 7.35% in Q1 2026.
Powered by 
Analysis
KORU Medical Systems (KRMD) EBITDA Margin (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported EBITDA Margin for 12 consecutive years, with 5.21% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 827.0% year-over-year to 5.21% in Q2 2026; TTM through Jun 2026 was 3.66%, a 888.0% increase from a year earlier, with the FY2025 full-year figure at 7.23%, up 1193.0% from the prior year.
- EBITDA Margin was 5.21% for Q2 2026 at KORU Medical Systems, up from 7.35% in the prior quarter.
- Over five years, EBITDA Margin peaked at 5.21% in Q2 2026 and troughed at 53.51% in Q2 2022.
- A 5-year average of 21.66% and a median of 18.01% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 3035 bps in 2022 and surged 3187 bps in 2024, its largest moves.
- Over 5 years, EBITDA Margin stood at 34.19% in 2022, then advanced by 11 bps to 30.58% in 2023, then soared by 41 bps to 17.98% in 2024, then jumped by 72 bps to 5.02% in 2025, then jumped by 204 bps to 5.21% in 2026.
- The last three EBITDA Margin figures came in at 5.21% (Q2 2026), 7.35% (Q1 2026), and 5.02% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | KORU Medical Systems | 144.70 Mn | 136.40 Mn | 7.85 Mn | 5.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.21% |
| Mar 31, 2026 | -7.35% |
| Dec 31, 2025 | -5.02% |
| Sep 30, 2025 | -8.34% |
| Jun 30, 2025 | -3.07% |
| Mar 31, 2025 | -12.92% |
| Dec 31, 2024 | -17.98% |
| Sep 30, 2024 | -18.04% |
| Jun 30, 2024 | -11.56% |
| Mar 31, 2024 | -21.30% |
| Dec 31, 2023 | -30.58% |
| Sep 30, 2023 | -22.72% |
| Jun 30, 2023 | -43.42% |
| Mar 31, 2023 | -38.68% |
| Dec 31, 2022 | -34.19% |
| Sep 30, 2022 | -17.79% |
| Jun 30, 2022 | -53.51% |
| Mar 31, 2022 | -48.56% |
| Dec 31, 2021 | -32.56% |
| Sep 30, 2021 | -20.22% |